Haematology Flashcards

1
Q

Translocation associated with mantle cell lymphoma

A

(11;14) translocation

(q13;q32) cyclin D1 (CCDN1) and immunoglobulin heavy chain (IgH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 2 GIIB/IIIB inhbitors

A

abciximab
eptifibatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Deficiency in:
- Bernard soulier
- grey platelet syndrome
- glanzmans thrombesthenia

A

BS - glycoprotein abnormalities
GPS - alpha granule deficiency
GT - GIIb/IIIB defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatment of essential thrombocytosis

A

If no JAK mutation, age <60yo, no vasomotor sx or CVS risk factors, can observe

Otherwise, aspirin daily (BD if CVS risk factors)

ADD hydroxyurea if high risk (i.e. previous clots, >60YO) with target platelets <400

ADD anticoagulation if previous VTE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What conditions is eculizumab inducated for?

A

PNH
Atypical HUS (complement mediated TMA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hepcidins action on iron

What effect does inflammation have on it?

A

Decreases serum iron

Inhibits ferroportin (major role)
- decreased recycling of iron from old RBCs/macs via the reticuloendothelial system
- decreased release of iron into the circulation at basolateral membrane of enterocytes

Inhibits intestinal iron absorption (minor role

Inflammation increases hepcidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common mutations in myelodysplastic syndromes

Which are associated with a poor prognosis?

A

TET2
SRSF2
ASXL1
DNMT3A
RUNX1

SRSF2, RUNX1 and TP53 = poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which form of MDS does lenalidomide work best in

A

isolated del5q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Poor prognostic markers in MM

A

High beta 2 microglobulin
Low albumin
t(4;14)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Standard treatment for MM if ineligible for transplant

What can be added if high risk?

A

Bortezomib (proteosome inhibitor)
Melphalan (akylating agent) or lanalidomide
Prednisone

Antibodies
- antiCD38: daratunumab, isatuximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common feature of MM

A

Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hodgkins lymphoma with best prognosis

worst prognosis?

A

Nodular sclerosing’

Lymphocyte depleted (worst)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Dohle bodies and when do they occur

A

Toxic granulation of neutrophils

Leukomoid rection - associated with high LAP socre and differentiating feature from CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Features of WM

A

Funduscopic abnormalities
Constitutional “B” symptoms
Bleeding
Neurologic symptoms
Hyperviscosity
Lymphadenopathy
Hepatomegaly
Splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does TCT test?

Name conditions where it will be prolonged

A

Fibrinogen conversion to fibrin (i.e. the action of thrombin)

Unfractionated heparin
Direct thrombin inhibitors (dabigatran)
Liver disease
DIC and acquired fibrinogen disorders
Hypoalbuminemia
Paraproteinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Abelacimab mechanism of action

A

Factor XI inhbitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Prolonged APTT with normal reptilase time indicates what

A

Heparin contamination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Test to distunguish secondary and primary polycythemia

A

EPO level
- low in primary
- high in secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Spindle cells and fibrosis on BM biopsy with elevate tryptase

Mutation?

A

Systemic mastocytosis

KIT mutations (D816V common)

20
Q

Empiric antibiotics for patients with febrile neutropenia life threatening penicillin allergy

Non-life threatening penicillin allergy?

A

Life threatening:
- aztreonam OR cipro
- AND vancomycin

Non-life threatening
- cefepime (no vanc)

21
Q

Empiric antibiotics for patients with febrile neutropenia and systemic compromise

A

As for non life threatening (pip-taz) and:
- ADD gentamycin
- ADD vanc if signs of cellulitis

If GI features and not on pip-taz/mero, need to cover for anaerobes with metronidazole

22
Q

What is daratunumab?
What is the major issue?

A

Anti-CD38, used in MM

Interferes with pre-transfusion cross match due to CD38 markers on RBCs

23
Q

Malignancy associated with “starry sky” picture on blood film

Mutation?

A

Burkitts Lymhoma

MYC;IgH translocation (8;14)

24
Q

What is gemtuzumab and when is it used?
Major issue?

A

Anti-CD33, used in AML (less common now)

causes hepatic sinusoidal obstructive(veno-occliusive) syndrome
Treat with defibrotide

25
CML translocation
t(9;22)
26
APML translocation
t(15;17)
27
Indications for treatment in CLL
Worsening anemia/thrombocytopenia Splenomegaly Lymphadenopathy Progressive lymphocytosis - doubling time <6 months OR increase >50% over 2 months Autoimmune anemia/thrombocytopenia poorly responsive to steroids Symptomatic/functional extranodal involvement (skin, kidney, lungs, spine) Constitutional symptoms - unintentional LOW, fevers, fatigue, night sweats
28
Poor prognostic markers in CLL
BIG ONE - Del(17p)/TP53 Lymphocyte doubling time <12 months Del(11q) Unmutated IGHV Age >60 High B2 microglobulin
29
Best evidence for prevention of post thrombotic syndrome
Anti-coagulation
30
Definition of MM
>10% clonal plasma cells + either of: - End organ damage (1 or more) - CRAB sx - presence of a biomarkers (1 or more) - ≥60% clonal plasma cells in BM, FLC ratio ≥100, MRI with >1 focal bone lesion
31
Chains in: - HbA - HbA2 - HBF - HBH - Hb Barts
HBA: 2 alpha, 2 beta (normal) HBA2: 2 alpha, 2 delta (beta thal) HBF: 2 alpha, 2 gamma HBH: 4 beta (alpha thal) Hb Barts: 4 gamma (alpha thal)
32
hemoglobin in sickle cell
HBS - 2 alpha, 2 beta Mutated beta chain
33
Mutation in sickle cell disease
missense mutation [Glu6Val, rs334] in the β-globin gene [HBB]
34
What is hemoglobin E? When is it significant?
HbA chains (2 alpha, 2 beta) with mutated beta chain Significant when occurs with beta thalasamia; significant beta chain reduction
35
Features of red cell aplasia
Normochromic, normocytic anemia elevated EPO Absent erythroblasts and f giant pronormoblasts in the bone marrow.
36
Microspherocytes are associated with what
Autoimmune hemolytic anemia
37
Poor prognostic features in ALL
Philadelphia chromosome (9;22) Male gender Age <2 or >10 Initial WCC >100 CNS involvement Non-caucasian FAB L3 T or B cell surface markers
38
Good prognostic features in ALL
FAB L1 Common ALL Pre-B phenotype Low initial WCC
39
In what organ is thrombopoetin mostly produced
Liver Small amounts produced in kidney and bone marrow
40
Effects of anticoagulants on coagulation studies: - Warfarin - Apixaban - Rivaroxaban - Dabigatran - Heparin
Warfarin - prolonged INR, variable APTT Apixaban, rivaroxaban - PT>APTT, TT normal Dabigatran - TT>APTT>PT Heparin - APTT>TT, normal reptilase, normal PT
41
Reason for increased VTE risk in malignancy
Increased tissue factor production by cancer cells --> excessive extrinsic pathway activation
42
Warm Autoimmune Haemolytic Anaemia? - Mech - Disease Assoc - Coombs? and BLood film - Tx
IgG and complement D: Drugs, Virus, Autoimmune, CLL - Direct commobs anti-IgG and anti-C3 positive - Microsphereocytes, Extravascular main in spleen Tx: steriods, splenectomy if refractory
43
Cold Autoimmune Haemolytic Anaemia? - Mech - Disease Assoc - Coombs? and BLood film - Tx
IgM bings + complement - destruction mainly in liver or intravascular for acute. Tx: rituxibab D: post infection, paroxysmal, lymphoproliferative diease Intravscular, agglutination.
44
Factor V Leiden mechanism?
Resitance to action of protien C factor. Most common iherited thrombophilia. Hetro = 5 x Homo - 50 fold risk
45
Polycythaemia rubra vera common transformations?
Myelofibrosis + AML Mx: veneestction, aspirin, hydroxyurea.